financetom
Business
financetom
/
Business
/
AGNC Investment's Q3 profit rises on Agency MBS strength
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AGNC Investment's Q3 profit rises on Agency MBS strength
Oct 20, 2025 1:45 PM

Overview

* AGNC Q3 net income per share at $0.72, with $0.36 dividends declared per share

* Tangible net book value per share rose 6% to $8.28

* AGNC's investment portfolio valued at $90.8 bln, mainly in Agency MBS

Outlook

* AGNC expects favorable conditions for Agency MBS due to manageable supply and growing demand

* Company sees solid financing market for Agency MBS despite U.S. Treasury issuance

* AGNC anticipates positive trends in GSE reform discussions emphasizing mortgage market stability

Result Drivers

* AGENCY MBS PERFORMANCE - Agency MBS outperformed U.S. Treasuries, contributing to AGNC's strong economic return on tangible common equity

* CAPITAL MARKETS ACTIVITY - AGNC raised $345 mln through Series H Preferred Stock and over $300 mln through common stock offerings, enhancing liquidity

* TANGIBLE NET BOOK VALUE GROWTH - Tangible net book value per share increased due to tighter mortgage spreads to benchmark rates

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 EPS $0.72

Q3 Net $806 mln

Income

Q3 Net $148 mln

Interest

Income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the specialized reits peer group is "buy"

* Wall Street's median 12-month price target for AGNC Investment Corp ( AGNC ) is $9.95, about 0.4% below its October 17 closing price of $9.99

* The stock recently traded at 6 times the next 12-month earnings vs. a P/E of 6 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: QXO Stepping Up Efforts to Win Over Beacon Roofing Supply Shareholders to Buyout
Update: QXO Stepping Up Efforts to Win Over Beacon Roofing Supply Shareholders to Buyout
Feb 11, 2025
10:56 AM EST, 02/11/2025 (MT Newswires) -- (Updates with QXO's comments in seventh, eighth and ninth paragraphs.) QXO (QXO) on Monday continued its push to persuade Beacon Roofing Supply ( BECN ) shareholders to accept its $124.25-per-share buyout offer, arguing that Beacon's board is misrepresenting aspects of the deal and undervaluing the proposal. Last week, Beacon's board reiterated its recommendation...
KULR Technology Expands Bitcoin Holdings With Additional $10 Million Purchase
KULR Technology Expands Bitcoin Holdings With Additional $10 Million Purchase
Feb 11, 2025
10:46 AM EST, 02/11/2025 (MT Newswires) -- KULR Technology Group ( KULR ) said Tuesday it grew its bitcoin purchases for its bitcoin treasury by a further $10 million to reach a total of about $60 million in such acquisitions. The company said it made the additional purchases at a weighted average price of $103,905 per bitcoin, adding that it...
Market Chatter: Goldman Sachs May Selectively Pursue Asset, Wealth Management Acquisitions, CEO Says
Market Chatter: Goldman Sachs May Selectively Pursue Asset, Wealth Management Acquisitions, CEO Says
Feb 11, 2025
10:55 AM EST, 02/11/2025 (MT Newswires) -- Goldman Sachs ( GS ) is open to acquisitions in asset and wealth management, but would be selective in its approach to any potential deals, Chief Executive David Solomon said Tuesday, according to Reuters. Solomon told a UBS financial services conference in Miami that the bank would consider things that could accelerate our...
Update: Travere Therapeutics Completes US FDA Meeting Ahead of Potential Kidney Disease Drug Submission; Shares Rise Over 13%
Update: Travere Therapeutics Completes US FDA Meeting Ahead of Potential Kidney Disease Drug Submission; Shares Rise Over 13%
Feb 11, 2025
10:59 AM EST, 02/11/2025 (MT Newswires) -- (Updates with recent share movement in the headline and first paragraph.) Travere Therapeutics ( TVTX ) shares were up over 13% in recent Tuesday trading after the company said it has completed a meeting with the US Food and Drug Administration and plans to submit a supplemental new drug application for approval of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved